Recall record at a glance
| Official record | F-0668-2025 |
|---|---|
| Category | Food Recalls |
| Classification | Class III |
| FDA record status | Terminated |
| Recalling firm | U.S. Tov, Inc. dba U.S. Trading Company |
| Report date | Apr 2, 2025 |
| Recall initiation date | Mar 3, 2025 |
| Quantity | 5200 packages |
| Location | Hayward, CA, United States |
Official product description
DRIED LILY FLOWERS Net Weight 2.5 oz (70g) Ingredients: Lily flower (Hemerocallis citrina) Distributed by: U.S. TRADING COMPANY Hayward, CA 94545-1130 Product of China
Why the product was recalled
Undeclared sulfites
Distribution information
AK, AL, AR, CA, CO, FL, HI, IA, IL, IN, KS, KY, MD, MN, MO, MS, MT, ND, NE, NV, NY, OH, OR, SD, TN, TX, UT, VA, WA, WI
How to read the classification
FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.